Prices delayed by at least 15 minutes | Print
PHARMING GROUP (PHARM)
PHARMING GROUPOpen
€0.8565
Previous close
€0.859
Trade high
€0.864
Volume
3,070,825
Year high
€1.31
Year low
€0.84
Dividend yield
-
Market capitalisation
€569.06 mn
P/E ratio
62.89
ISIN
NL0010391025
This share can be held in a Dealing accountISALifetime ISAJISASIPP
Share price
Company profile
Pharming Group is a global biopharmaceutical company dedicated to transforming the lives of patients with rare, debilitating, and life-threatening diseases. It is commercializing and developing an innovative portfolio of protein replacement therapies and precision medicines to serve the unserved rare disease patients. Its product includes Ruconest. The revenue is generated from the United States.
AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2024 AJ Bell. All rights reserved.